Structural Genomics Consortium
Business Services · Canada · 201-500 Employees
View Company Info for Free
Overview
Headquarters
101 College St Ste 700, Toronto, Ontario...Phone Number
(416) 946-0237Website
www.thesgc.orgRevenue
$16.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Structural Genomics Consortium
The Structural Genomics Consortium (SGC) is a global public-private partnership dedicated to understanding the functions of all human proteins to accelerate drug discovery through open-access research. They focus on determining protein structures and developing chemical probes, employing artificial intelligence to transform early drug discovery. SGC invites contributions of purified proteins from the scientific community to enhance large-scale protein-ligand interaction screenings. With a strong emphasis on collaboration and open science, SGC aims to foster innovation in drug discovery across academia and industry.Explore more
Structural Genomics Consortium Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Structural Genomics Consortium your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Structural Genomics Consortium has new funding data
Check if Structural Genomics Consortium has recently received funding, and reach out quickly before it becomes old news!
Structural Genomics Consortium, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Structural Genomics Consortium
Check out if Structural Genomics Consortium is spiking on competitors!
Earning: See what the market has to say on Structural Genomics Consortium recently announced quarterly report
Click to see if Structural Genomics Consortium had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Structural Genomics Consortium launches new products
Recommended Actions
Reach out to Masked Content who joined Structural Genomics Consortium as Masked Content
Find 3 more new buyers
Compare Similar Companies to Structural Genomics Consortium
Compare insights from companies similar to Structural Genomics Consortium, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Structural Genomics Consortium is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Structural Genomics Consortium is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Structural Genomics Consortium.
Structural Genomics Consortium Tech Stack
Most Recent Scoops
Open Position
Hiring Plans
Structural Genomics Consortium is hiring in Engineering & Technical for the first time in 12 months.
Hiring Plans
Event
Events
Event
Structural Genomics Consortium News & Media
X-Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science
WALTHAM, Mass.--(BUSINESS WIRE)-- #DrugDiscovery--X-Chem and the Structural Genomics Consortium (SGC) have entered a collaboration aimed at creating new chemical tools to study human proteins.Cyclica and the Structural Genomics Consortium Co-crystallize DCAF1, a Key Component in Proteasomal Degradation, With a Novel Ligand to Support Targeted Therapeutics Discovery
TORONTO--(BUSINESS WIRE)-- #DCAF1--Cyclica, the partner of choice for data-driven drug discovery, and the Structural Genomics Consortium (SGC), a global public-private partnership dedicated to open science, have collaborated on a project in support of Target 2035, an initiative to discover probe molecules in support of developing medicines for all. As part of the initiative, the SGC and Cyclica examined three WDR proteins to discover small molecule binders using Cyclica’s proprietary deep learniXORTX Therapeutics Announces Appointment of Allan Williams and Paul Van Damme
CALGARY, Alberta, Jan. 29, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE:XRX), a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces the appointment of Allan Williams and Paul Van Damme as directors of the Company and the resignation of Dr. Alan Moore as director. Dr. Alan Moore, a co-founder and a long time director of XORTX will remain with the Company as Senior Executive Consultant for
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Structural Genomics Consortium
Sign Up For FreeTo access detailed company insights
The Structural Genomics Consortium (SGC) is a global public-private partnership dedicated to understanding the functions of all human proteins to accelerate drug discovery through open-access research. They focus on determining protein structures and developing chemical probes, employing artificial intelligence to transform early drug discovery. SG... Read More
